191 related articles for article (PubMed ID: 15762219)
1. Metastasizing atypical fibroxanthoma (cutaneous malignant histiocytoma): report of five cases.
Cooper JZ; Newman SR; Scott GA; Brown MD
Dermatol Surg; 2005 Feb; 31(2):221-5; discussion 225. PubMed ID: 15762219
[TBL] [Abstract][Full Text] [Related]
2. Atypical fibroxanthoma with regional lymph node metastasis: report of a case and review of the literature.
New D; Bahrami S; Malone J; Callen JP
Arch Dermatol; 2010 Dec; 146(12):1399-404. PubMed ID: 20713774
[TBL] [Abstract][Full Text] [Related]
3. Localized cutaneous metastases from an atypical fibroxanthoma.
Giuffrida TJ; Kligora CJ; Goldstein GD
Dermatol Surg; 2004 Dec; 30(12 Pt 2):1561-4. PubMed ID: 15606841
[TBL] [Abstract][Full Text] [Related]
4. Atypical fibroxanthoma and malignant fibrous histiocytoma of the skin.
Rizzardi C; Angiero F; Melato M
Anticancer Res; 2003; 23(2C):1847-51. PubMed ID: 12820468
[TBL] [Abstract][Full Text] [Related]
5. [A rare low-grade malignant scalp tumor. Atypical fibroxanthoma].
Stepanova A; Marsch WC; Stadie V
Hautarzt; 2005 Jul; 56(7):679-82. PubMed ID: 15726303
[TBL] [Abstract][Full Text] [Related]
6. An unusual presentation of atypical fibroxanthoma.
Vandergriff TW; Reed JA; Orengo IF
Dermatol Online J; 2008 Jan; 14(1):6. PubMed ID: 18319023
[TBL] [Abstract][Full Text] [Related]
7. Recurrent Atypical Fibroxanthoma Versus Malignant Fibrous Histiocytoma.
Branch LG; Albertini JG; Leshin B
J Craniofac Surg; 2015 Jun; 26(4):e322-3. PubMed ID: 26080249
[TBL] [Abstract][Full Text] [Related]
8. Superficial malignant fibrous histiocytoma presenting as recurrent atypical fibroxanthoma.
Ly H; Selva D; James CL; Huilgol SC
Australas J Dermatol; 2004 May; 45(2):106-9. PubMed ID: 15068457
[TBL] [Abstract][Full Text] [Related]
9. Recurrent atypical fibroxanthoma of the cheek.
Skoulas IG; Price M; Andrew JE; Kountakis SE
Am J Otolaryngol; 2001; 22(1):73-5. PubMed ID: 11172219
[TBL] [Abstract][Full Text] [Related]
10. Atypical fibrous histiocytoma and atypical fibroxanthoma: presentation of two cases.
Kram A; Stańczyk J; Woyke S
Pol J Pathol; 2003; 54(4):267-71. PubMed ID: 14998296
[TBL] [Abstract][Full Text] [Related]
11. Melanoma simulating atypical fibroxanthoma.
Sangüeza M; Zelger B
Am J Dermatopathol; 2007 Dec; 29(6):551-4. PubMed ID: 18032950
[TBL] [Abstract][Full Text] [Related]
12. Atypical Fibroxanthoma - Histological Diagnosis, Immunohistochemical Markers and Concepts of Therapy.
Koch M; Freundl AJ; Agaimy A; Kiesewetter F; Künzel J; Cicha I; Alexiou C
Anticancer Res; 2015 Nov; 35(11):5717-35. PubMed ID: 26503993
[TBL] [Abstract][Full Text] [Related]
13. Clear cell atypical fibroxanthoma:a clinicopathologic study.
Crowson AN; Carlson-Sweet K; Macinnis C; Taylor JR; Battaglia T; LaMar WL; Minor D; Sutter S; Hill T
J Cutan Pathol; 2002 Jul; 29(6):374-81. PubMed ID: 12135470
[TBL] [Abstract][Full Text] [Related]
14. Atypical fibroxanthoma in a young female misdiagnosed clinically as a malignant melanoma--An unusual presentation.
Pujani M; Hassan MJ; Jetley S
J Cancer Res Ther; 2015; 11(4):1027. PubMed ID: 26881598
[TBL] [Abstract][Full Text] [Related]
15. Atypical fibroxanthoma versus benign and malignant fibrous histiocytoma. A comparative study of their proliferative activity using MIB-1, DNA flow cytometry, and p53 immunostaining.
Oshiro Y; Fukuda T; Tsuneyoshi M
Cancer; 1995 Mar; 75(5):1128-34. PubMed ID: 7850711
[TBL] [Abstract][Full Text] [Related]
16. Metastasizing "benign" cutaneous fibrous histiocytoma: a clinicopathologic analysis of 16 cases.
Doyle LA; Fletcher CD
Am J Surg Pathol; 2013 Apr; 37(4):484-95. PubMed ID: 23426120
[TBL] [Abstract][Full Text] [Related]
17. Utility of p63 in the differential diagnosis of atypical fibroxanthoma and spindle cell squamous cell carcinoma.
Gleason BC; Calder KB; Cibull TL; Thomas AB; Billings SD; Morgan MB; Hiatt KM; Smoller BR
J Cutan Pathol; 2009 May; 36(5):543-7. PubMed ID: 19476522
[TBL] [Abstract][Full Text] [Related]
18. Benign fibrous histiocytoma of the skin metastasizing to the inguinal lymph node.
Szumera-Ciećkiewicz A; Ptaszyński K
Pol J Pathol; 2011 Sep; 62(3):183-6. PubMed ID: 22102079
[TBL] [Abstract][Full Text] [Related]
19. LN2, CD10, and Ezrin Do Not Distinguish Between Atypical Fibroxanthoma and Undifferentiated Pleomorphic Sarcoma or Predict Clinical Outcome.
Hanlon A; Stasko T; Christiansen D; Cyrus N; Galan A
Dermatol Surg; 2017 Mar; 43(3):431-436. PubMed ID: 28079637
[TBL] [Abstract][Full Text] [Related]
20. Atypical fibroxanthoma (AFX).
Espino-Ardila C; Goldberg LH
Dermatol Nurs; 2005 Jun; 17(3):207. PubMed ID: 16035424
[No Abstract] [Full Text] [Related]
[Next] [New Search]
